← FDA Drug Approvals (Drugs@FDA)

DECITABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2017-11-16

Drug application

FDA Application #

ANDA208601

Application type

Abbreviated New Drug Application (Generic)

Brand name

DECITABINE

Generic name

Decitabine

Active ingredients

DECITABINE

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

CIPLA

First approval

2017-11-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown